4.7 Article

Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients

出版社

SPRINGER
DOI: 10.1007/s00259-013-2532-6

关键词

SPECT/CT; Bone scintigraphy; Bone metastases; Prostate cancer; Breast cancer

向作者/读者索取更多资源

This study was designed to assess the additional value of SPECT/CT of the trunk used in conjunction with conventional nuclear imaging and its effects on patient management in a large patient series. In 353 patients, whole-body scintigraphy (WBS), SPECT, and SPECT/CT were prospectively performed for staging and restaging. SPECT/CT of the trunk was performed in all patients. In the 308 evaluable patients (211 with breast cancer, 97 with prostate cancer), clinical follow-up was used as the gold standard. Bone metastases were confirmed in 72 patients and excluded in 236. Multistep analyses per lesion and per patient were performed. Clinical relevance was expressed in terms of downstaging and upstaging rates on a per-patient basis. In the total patient group, sensitivities, specificities, and negative and positive predictive values on a per-patient basis were 93 %, 78 %, 95 % and 59 % for WBS, 94 %, 71 %, 97 % and 53 % for SPECT, and 97 %, 94 %, 97 % and 88 % for SPECT/CT, respectively. In all subgroups, specificity and positive predictive value were significantly (p < 0.01) better with SPECT/CT. Downstaging of metastatic disease in the total, breast cancer and prostate cancer groups using SPECT/CT was possible in 32.1 %, 33.8 % and 29.5 % of patients, respectively. Upstaging in previously negative patients by additional SPECT/CT was observed in three breast cancer patients (2.1 %). Further diagnostic imaging procedures for unclear scintigraphic findings were necessary in only 2.5 % of patients. SPECT/CT improved diagnostic accuracy for defining the extent of multifocal metastatic disease in 34.6 % of these patients. SPECT/CT significantly improved the specificity and positive predictive value of bone scintigraphy in cancer patients. In breast cancer patients, we found a slight increase in sensitivity. SPECT/CT had a significant effect on clinical management because of correct downstaging and upstaging, better definition of the extent of metastases, and a reduction in further diagnostic procedures.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Radiology, Nuclear Medicine & Medical Imaging

177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?

Kambiz Rahbar, Hojjat Ahmadzadehfar, Martin Boegemann

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30

Milka Marinova, Martin Muecke, Lukas Mahlberg, Markus Essler, Henning Cuhls, Lukas Radbruch, Rupert Conrad, Hojjat Ahmadzadehfar

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Article Oncology

Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy

Yuri Tolkach, Heidrun Gevensleben, Ralph Bundschuh, Aydan Koyun, Daniela Huber, Christina Kehrer, Thomas Hecking, Mignon-Denise Keyver-Paik, Christina Kaiser, Hojjat Ahmadzadehfar, Markus Essler, Walther Kuhn, Glen Kristiansen

BREAST CANCER RESEARCH AND TREATMENT (2018)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion

Kambiz Rahbar, Matthias Weckesser, Hojjat Ahmadzadehfar, Michael Schaefers, Lars Stegger, Martin Boegemann

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Predictive Factors of Response and Overall Survival in Patients with Castration-Resistant Metastatic Prostate Cancer Undergoing 177Lu-PSMA Therapy

Hojjat Ahmadzadehfar, Markus Essler

JOURNAL OF NUCLEAR MEDICINE (2018)

Article Oncology

Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes

Johannes Linxweiler, Matthias Saar, Zaid Al-Kailani, Martin Janssen, Samer Ezziddin, Michael Stoeckle, Stefan Siemer, Carsten-Henning Ohlmann

SURGICAL ONCOLOGY-OXFORD (2018)

Article Gastroenterology & Hepatology

Practice guideline neuroendocrine tumors AWMF-Reg. 021-27

Anja Rinke, Bertram Wiedenmann, Christoph Auernhammer, Peter Bartenstein, Detlef K. Bartsch, Nehara Begum, Siegbert Faiss, Christian Fottner, Bernhard Gebauer, Peter Goretzki, Petra Lynen Jansen, Gabriele Poepperl, Hans Scheruebl, Matthias M. Weber, Thomas Mathias Gress, Marianne Pavel, Jorg Albert, Heiko Alfke, Holger Amthauer, Martin Anlauf, Rudolf Arnold, Richard Baum, Timm Denecke, Samer Ezziddin, Volker Fendrich, Stefan Gniffke, Alexander Haug, Dieter Hoersch, Thomas Kegel, Wolfram Trudo Knoefel, Thomas Knoesel, Clemens Kratochwil, Harald Lahner, Florian Lordick, Markus Luster, Andreas Mahnken, Katharina Mellar, Heiner Moenig, Thomas J. Musholt, Monika Nothacker, Ulrich-Frank Pape, Andreas Pascher, Thorsten Poeppel, Vikas Prasad, Andreas Probst, Klemens Scheidhauer, Dominik Schneider, Matthias Schott, Joerg Schrader, Thomas Seufferlein, Bence Sipos, Christine Spitzweg, Thomas Steinmueller, Christoph Trumm, Christine Wurst, Niels Zorger

ZEITSCHRIFT FUR GASTROENTEROLOGIE (2018)

Letter Radiology, Nuclear Medicine & Medical Imaging

It is time to move forward into the era of Theranostics

Hojjat Ahmadzadehfar, Markus Essler

EJNMMI RESEARCH (2018)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Large Paraesophageal Schwannoma With Intense Prostate-Specific Membrane Antigen Expression on 68Ga-PSMA-PET/CT Mimicking Lymph Node Metastasis in a Patient With Prostate Cancer

Martin Ries, Fadi Khreish, Christian Veith, Joachim von den Hoff, Samer Ezziddin

CLINICAL NUCLEAR MEDICINE (2019)

Article Environmental Sciences

Radionuclide intake risks in the clinical administration of 223RaCl2

Clemens Scholl, Ralph A. Bundschuh, Stefan Hirzebruch, Tim Glanert, Xiao Wei, Stefan Kuerpig, Roland Roedel, Markus Essler, Lena Thomas, Hojjat Ahmadzadehfar

JOURNAL OF RADIOLOGICAL PROTECTION (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Quality of life in patients with midgut NET following peptide receptor radionuclide therapy

Milka Marinova, Martin Muecke, Felix Fischer, Markus Essler, Henning Cuhls, Lukas Radbruch, Shiwa Ghaei, Rupert Conrad, Hojjat Ahmadzadehfar

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Review Pharmacology & Pharmacy

Bench-to-Bedside Theranostics in Nuclear Medicine

Narges Jokar, Majid Assadi, Anna Yordanova, Hojjat Ahmadzadehfar

CURRENT PHARMACEUTICAL DESIGN (2020)

Review Pharmacology & Pharmacy

Precision Medicine Approach in Prostate Cancer

Majid Assadi, Narges Jokar, Mojtaba Ghasemi, Iraj Nabipour, Ali Gholamrezanezhad, Hojjat Ahmadzadehfar

CURRENT PHARMACEUTICAL DESIGN (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study

Hojjat Ahmadzadehfar, Ralf Matern, Richard P. Baum, Robert Seifert, Katharina Kessel, Martin Boegemann, Clemens Kratochwil, Hendrik Rathke, Harun Ilhan, Hanna Svirydenka, Mike Sathekge, Levent Kabasakal, Anna Yordanova, Francisco Osvaldo Garcia-Perez, Kalevi Kairemo, Masha Maharaj, Diana Paez, Irene Virgolini, Kambiz Rahbar

Summary: The extent of bone metastases negatively correlated with overall survival after RLT, but showed no significant correlation with PSA response rate. Prior therapy with Ra-223 may have a positive impact on overall survival.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action

Majid Assadi, Seyed Javad Rekabpour, Abdullatif Amini, Habibollah Dadgar, Reza Nemati, Ali Gholamrezanezhad, Iraj Nabipour, Esmail Jafari, Hojjat Ahmadzadehfar

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY (2021)

暂无数据